Tennis Elbow
Conditions
Interventions
Iontophoresis group: 12 subjects were given the drug Dexamethasone 4mg / ml and 4% Gelidocaine 4% in gel via direct current with initial intensity of 5 mA and application time of 15 minutes three time
Procedure/surgery
E02.331.750
E02.331
Sponsors
Universidade Luterana do Brasil
Universidade Luterana do Brasil
Eligibility
Inclusion criteria
Inclusion criteria: Have signed the informed consent form (TCLE); clinical diagnosis of lateral elbow epincondylalgia (ELC), uni- or bilateral; have not received any kind of treatment.
Exclusion criteria
Exclusion criteria: Shoulder, neck (radiculopathy) and / or thoracic region dysfunction; local or generalized arthritis; neurological deficit; trapping of the radial nerve; limitations in arm functions; Have received conservative treatment for ELC within four weeks before entering the study; neoplasia diagnosed at the treatment site; patient with a history of adverse reaction or hypersensitivity to electrical stimulation; contraindications to the medication to be administered; pain or symptoms of unknown origin.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduction of the pain in the lateral region of the elbow at rest and in the effort evaluated through the Visual Analog Pain Scale (VAS) from pre to post intervention. | — |
Secondary
| Measure | Time frame |
|---|---|
| Improved level of functionality by reducing scores on the Patient-Rated Tennis Elbow Evaluation (PRTEE) questionnaire and improving pre and post-intervention hand grip strength. | — |
Countries
Brazil
Contacts
Public ContactMarcelo Dohnert
Universidade Luterana do Brasil
Outcome results
None listed